Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Clinical Lung Cancer|July 17, 2023
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung CancerFlorian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.
Cancer Letters|August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomasMichael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 15, 2024
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancerSarah Richtmann, Sebastian Marwitz, Thomas Muley, et al.
International Journal of Molecular Sciences|October 25, 2016
A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on SurvivalMathieu Pecqueux, Isabell Liebetrau, Wiebke Werft, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
European Journal of Medical Research|August 15, 2015
Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomasJuliane Rieber, Julian Schmitt, Arne Warth, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2009
Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodulesNicolas Kahn, Ruprecht Kuner, Ralf Eberhardt, et al.
European Journal of Radiology|May 21, 2014
Morphological computed tomography features of surgically resectable pulmonary squamous cell carcinomas: impact on prognosis and comparison with adenocarcinomasMarcel Koenigkam Santos, Thomas Muley, Arne Warth, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Clinical Lung Cancer|July 17, 2023
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung CancerFlorian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.
Cancer Letters|August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomasMichael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 15, 2024
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancerSarah Richtmann, Sebastian Marwitz, Thomas Muley, et al.
International Journal of Molecular Sciences|October 25, 2016
A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on SurvivalMathieu Pecqueux, Isabell Liebetrau, Wiebke Werft, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
European Journal of Medical Research|August 15, 2015
Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomasJuliane Rieber, Julian Schmitt, Arne Warth, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2009
Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodulesNicolas Kahn, Ruprecht Kuner, Ralf Eberhardt, et al.
European Journal of Radiology|May 21, 2014
Morphological computed tomography features of surgically resectable pulmonary squamous cell carcinomas: impact on prognosis and comparison with adenocarcinomasMarcel Koenigkam Santos, Thomas Muley, Arne Warth, et al.
Pageof 23